Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy
Elaine McKevitt, Rona Cheifetz, Kimberly DeVries, et al.
Annals of Surgical Oncology (2021) Vol. 28, Iss. 11, pp. 5950-5957
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Personalizing Adjuvant Endocrine Therapy for Early-Stage Hormone Receptor–Positive Breast Cancer
Barbara Pistilli, Caroline Lohrisch, Jori Sheade, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 60-72
Closed Access | Times Cited: 37
A Prospective Study of Sentinel Node Biopsy Omission in Women Age ≥ 65 Years with ER+ Breast Cancer
Alice Chung, Catherine Dang, Scott Karlan, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 5, pp. 3160-3167
Open Access | Times Cited: 5
Does Sentinel Lymph Node Biopsy Influence Subsequent Management Decisions in Women With Breast Cancer ≥ 70 Years Old?
Gordon R. Daly, Gavin P. Dowling, Eman Hamza, et al.
Clinical Breast Cancer (2024) Vol. 24, Iss. 6, pp. 510-518.e4
Open Access | Times Cited: 5
Adjuvant chemotherapy in elderly patients with HER2-negative early breast cancer: A systematic review and meta-analysis
Fausto Petrelli, Lorenzo Dottorini, Italo Sarno, et al.
Tumori Journal (2025)
Closed Access
The Role of Molecular Profiling in De-Escalation of Toxic Therapy in Breast Cancer
Sonia Y. Khan, Tonjeh Mary Stella Bah, Rakhshanda Layeequr Rahman
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1332-1332
Open Access
Omission of Axillary Surgery After Neoadjuvant Therapy in Her2-Positive Breast Cancer: Who Are the Candidates?
Omar Hamdy, Khalid Atallah, Alyaa R. Elsergany, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 562-562
Open Access
Frequency of use and characterization of frailty assessments in observational studies on older women with breast cancer: a systematic review
Dafne N. Sanchez, Marloes G.M. Derks, Jose A. Verstijnen, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
The implementation of NILS: A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer
Looket Dihge, Pär‐Ola Bendahl, Ida Skarping, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Addressing the problem of overtreatment in breast cancer
Linda M. Pak, Monica Morrow
Expert Review of Anticancer Therapy (2022) Vol. 22, Iss. 5, pp. 535-548
Open Access | Times Cited: 11
The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer
Ida Skarping, Kristoffer Nilsson, Looket Dihge, et al.
Breast Cancer Research and Treatment (2022) Vol. 194, Iss. 3, pp. 577-586
Open Access | Times Cited: 11
Omitting SLNB in Breast Cancer: Is a Nomogram the Answer?
A. M. Moorman, Emiel J. Rutgers, E.A. Kouwenhoven
Annals of Surgical Oncology (2021) Vol. 29, Iss. 4, pp. 2210-2218
Closed Access | Times Cited: 13
Low RUFY3 expression level is associated with lymph node metastasis in older women with invasive breast cancer
Fernando A. Angarita, Masanori Oshi, Akimitsu Yamada, et al.
Breast Cancer Research and Treatment (2022) Vol. 192, Iss. 1, pp. 19-32
Open Access | Times Cited: 9
Incorporating Value-Based Decisions in Breast Cancer Treatment Algorithms
Ton Wang, Lesly A. Dossett
Surgical Oncology Clinics of North America (2023) Vol. 32, Iss. 4, pp. 777-797
Closed Access | Times Cited: 4
Impact of sentinel lymph node biopsy on management of older women with clinically node-negative, early-stage, ER+/HER2-, invasive breast cancer: a systematic review and meta-analysis
Gordon R. Daly, Gavin P. Dowling, Mohammad Said, et al.
Clinical Breast Cancer (2024) Vol. 24, Iss. 8, pp. e681-e688.e1
Closed Access | Times Cited: 1
Controversial Areas in Axillary Staging: Are We Following the Guidelines?
Ava Armani, Sasha Douglas, Swati Kulkarni, et al.
Annals of Surgical Oncology (2021) Vol. 28, Iss. 10, pp. 5580-5587
Open Access | Times Cited: 9
Can We Forgo Sentinel Lymph Node Biopsy in Women Aged ≥ 50 Years with Early-Stage Hormone-Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?
Nicole M. Knape, Ji‐Hye Park, Chris B. Agala, et al.
Annals of Surgical Oncology (2022) Vol. 30, Iss. 2, pp. 1042-1050
Closed Access | Times Cited: 5
Clinical prediction model based on 18F-FDG PET/CT plus contrast-enhanced MRI for axillary lymph node macrometastasis
Shun Kawaguchi, Nobuko Tamura, Kiyo Tanaka, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Surgical Management of the Axilla in Breast Cancer: Evolving but Still Necessary
Theresa Schwartz, Ashley Marumoto, Armando E. Giuliano
Annals of Surgical Oncology (2022) Vol. 30, Iss. 2, pp. 1008-1013
Closed Access | Times Cited: 3
Incorporating Value-Based Decisions in Breast Cancer Treatment Algorithms
Ton Wang, Lesly A. Dossett
(2024) Vol. 14, Iss. 1, pp. 241-261
Closed Access
Evaluating the Necessity for Routine Sentinel Lymph Node Biopsy in Postmenopausal Patients Being Treated for Clinically Node Negative Breast Cancer the Era of RxPONDER
Matthew G. Davey, Eoin Kerin, Ray McLaughlin, et al.
Clinical Breast Cancer (2023) Vol. 23, Iss. 5, pp. 500-507
Open Access | Times Cited: 1
Surgical de-escalation: Are we ready for ‘observation’ of benign high-risk breast lesions found on core needle biopsy?
Holly J. Pederson, Debra A. Pratt, Benjamin C. Calhoun
Cleveland Clinic Journal of Medicine (2023) Vol. 90, Iss. 7, pp. 433-438
Open Access | Times Cited: 1
Survival benefit from axillary surgery in patients aged 70 years or older with clinically node-negative breast cancer: A population-based propensity-score matched analysis
Chihwan Cha, Joon Jeong, Hong‐Kyu Kim, et al.
European Journal of Surgical Oncology (2022) Vol. 48, Iss. 12, pp. 2385-2392
Closed Access | Times Cited: 2
Mucinous carcinoma in an octogenarian: Treatment and management of breast cancer in the elderly
Victoria Risner, Sheryl G. Jordan
Radiology Case Reports (2021) Vol. 16, Iss. 11, pp. 3201-3207
Open Access | Times Cited: 2
NILS: An Artificial Neural Network Tool for Personalized Noninvasive Lymph Node Staging in Breast Cancer
Looket Dihge, Pär‐Ola Bendahl, Ida Skarping, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
ASO Author Reflections: Selective Nodal Staging and De-escalating Adjuvant Therapy
Elaine McKevitt, Alan Nichol
Annals of Surgical Oncology (2021) Vol. 28, Iss. 11, pp. 5958-5959
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top